Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: A pilot field study

American Journal of Drug and Alcohol Abuse

Volumn 37, Issue 2, 2011, Pages 131-136

  Mancino, Michael J ^a   Gentry, Brooks W ^b   Feldman, Zachary ^a   Mendelson, John ^c   Oliveto, Alison ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive function; Methamphetamine withdrawal; Mood; Sleep

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MALE; METHAMPHETAMINE DEPENDENCE; MOOD DISORDER; RESIDENTIAL CARE; SLEEP DISORDER; WITHDRAWAL SYNDROME;

ADULT; AFFECT; AMPHETAMINE-RELATED DISORDERS; ANXIETY; BLOOD PRESSURE; COGNITION; FEMALE; HEART RATE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SLEEP; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 79951478261     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2010.543998     Document Type: Article

References (27)

1. Murray J. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol 1998; 132:227-237. (Pubitemid 128469739)
2. Rawson RA, Anglin MD, Ling W. Will the methamphetamine problem go away? J Addict Dis 2002; 21:5-19. (Pubitemid 35203850)
3. Kosten TR. Neurobiology of abused drugs. Opioids and stimulants. J Nerv Ment Dis 1990; 178:217-227. (Pubitemid 20134863)
4. Albertson TE, Derlet RW, Van Hoozen BE. Metham-phetamine and the expanding complications of amphetamines. West J Med 1999; 170:214-219.
5. NACO. The Meth Epidemic in America. Washington, DC: The National Association of Counties, 2005.
6. APA. Diagnostic and Statistical Manual for Mental Disorders 2000. Washington, DC: APA, 2000.
7. Cantwell B, McBride AJ. Self-detoxification by amphetamine dependent patients: A pilot study. Drug Alcohol Depend 1998; 49:157-163. (Pubitemid 28111902)
8. Gossop MR, Bradley BP, Brewis RK. Amphetamine withdrawal and sleep disturbances. Drug Alcohol Depend 1982; 10:177-183.
9. Shoptaw SJ, Kao U, Heinzerling K, Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009; 2:CD003021.
10. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment of amphetamine withdrawal. Cochrane Database Syst Rev 2001; (4). CD003021.
11. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100:1320-1329. (Pubitemid 41248073)
12. Monroe RR, Drell HZ. Oral use of stimulants obtained from inhalers. J Am Med Assoc 1947; 135:909-915.
13. Hawks D, Mitcheson M, Ogborne A, Edwards G. Abuse of methylamphetamine. Br Med J 1969; 21:715-721.
14. Angrist B, Sudilovsky A. Central nervous system stimulants: Historical aspects and clinical effects. In Handbook of Psychopharmacology, Vol 11: Stimulants. Iversen SD, Iversen LL, Snyder SH, eds. New York, NY: Plenum Press, 1978; 99-165.
15. Kales A, Heuser G, Kales JD, Rickles WH, Jr, Rubin RT, Scharf MB, Ungerleider JT, Winters WD. Drug dependency. Investigations of stimulants and depressants. Ann Intern Med 1969; 70:591-614.
16. Trevisan LA, Boutros N, Petrakis IL, Krystal JH. Complications of alcohol withdrawal: Pathophysiological insights. Alcohol Health Res World 1998; 22:61-66.
17. Koob GF. Neurobiology of addiction: Toward the development of new therapies. Ann N Y Acad Sci 2000; 909: 170-185. (Pubitemid 30462039)
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960; 23:56-62.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55.
20. Carskadon MA, Dement WC, Mitler MM, Guilleminault C, Zarcone VP, Spiegel R. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 1976; 133:1382-1388.
21. Reitan KM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955; 19:393-394.
22. Kaplan E, Fein D, Morris R, Delis DC. WAIS-R as a Neuropsychological Instrument. Toronto, ON: Harcourt Brace Jovanovich, Inc., 1991.
23. Golden CJ. Stroop Color and Word Test. Wood Dale, IL: Stoelting Co., 1978.
24. Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003; 15:215-220. (Pubitemid 36520342)
25. Monterosso JR, Aron AR, Cordova X, Xu J, London ED. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79:273-277. (Pubitemid 40942119)
26. Rawson R, Gonzales R, Brethen P. Treatment of metham-phetamine use disorders: An update. J Subst Abuse Treat 2002; 23:145-50. (Pubitemid 36151695)
27. Vocci F. Medication development for methamphetamine-related disorders. Presented to the Methamphetamine Advisory Group to Attorney General Reno, Washington, DC, May 1998.